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http://dx.doi.org/10.1016/j.jmii.2013Background/Purpose: Infectious parapneumonic effusion (PE) contains proteins originating
from circulation as well as proteins locally released by inflammatory pulmonary cells. The pur-
pose of this study was to investigate the value of total protein analysis in guiding management
of infectious PE by using matrix-assisted laser desorption/ionization time-of-flight mass spec-
trometry.
Methods: Fifty-seven children with pneumonia followed by PE were consecutively enrolled
into our study. Protein profiles generated by matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry after fractionating samples with functionalized magneticof Pediatrics, Chang Gung Memorial Hospital, 5, Fu-Hsin Street, Kueishan, Taoyuan, Taiwan.
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484 C.-Y. Chiu et al.beads (C8) were used for differentiating complicated PE (CPE) from non-CPE. A training set
was used to generate classification models and the clinical efficacy of these models in detect-
ing CPE and the need for intervention was then evaluated in an independent set.
Results: The MS spectra derived from PE were analyzed, and classification models were con-
structed in the training set. A total of 123 mass/charge (m/z) values were identified and
23 m/z values which were significant with p < 0.05 were used as classifiers. An optimized
genetic algorithm model containing enforced selection of three significant downregulated
m/z values (2127, 2232, and 2427) was able to classify CPE with 100% positive predictive value
and predict the need of aggressive therapeutic intervention with 77% positive predictive value.
Conclusion: A diagnostic model construction comprising three potential biomarkers can pre-
dict CPE and need for surgical intervention rapidly and precisely. Pleural fluid proteins down-
regulated during the progression of pneumonia could potentially guide the management of
infectious PE.
Copyright ª 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Community-acquired pneumonia is a common infectious
illness in children and complicated parapneumonic effusion
(CPE) is a well-recognized complication of bacterial pneu-
monia.1 Failing adequate therapy to control the pleural
inflammation may lead to progressive pleural thickening
and fibrin deposition, resulting in organizing empyema. The
therapeutic strategies for parapneumonic effusion (PE)
vary from a conservative approach with adequate antibiotic
therapy, expedient drainage including thoracentesis, tube
thoracostomy, or surgical drainage.2 However, the optimal
time of intervention for PE and empyema in pediatric pa-
tients remains a challenge in clinical practice.
Infectious pleural fluid accumulation is posited to be a
continuing process of pleural inflammation and is mainly a
result of inflammatory response caused by pneumonia.
Clinically, biochemical analysis of pleural effusion plays an
important role in the management of pleural effusions.3 In
general practice, pleural infection is indicated by acidosis
associated with raised lactate dehydrogenase (LDH) and
low glucose levels. The indicators of pH  7.2,
LDH  1000 U/L and glucose 40 mg/dL are characteristics
of CPE that are more likely to require aggressive in-
terventions.3,4 Despite this, several inflammatory media-
tors such as tumor necrosis factor-a, interleukin-1b, and
interleukin-6 have been reported to have a significant
role in pyogenic infections in the pleural space.5e7 A recent
study has also shown that not only pleural fluid proin-
flammatory cytokines but also anti-inflammatory cytokines
are accurate in discriminating complicated effusions.8 It is
therefore believed that proteins in pleural fluids could
potentially be useful as markers of CPE for guiding clinical
management.
Use of proteomics techniques to identify disease-specific
protein biomarkers is a powerful tool for defining prognosis
of disease.9,10 The discovery of biomarkers, proteins that
change in concentration or state in association with a
specific biological process can help to gain deep insights
into disease mechanisms in which proteins play a major
role. Several studies have shown that pleural effusion
contains proteins originating from circulation as well as
proteins locally released by inflammatory or epithelialcells.11 The pleural exudates from a patient with severe
pneumonia have been investigated and contain proteins of
potential diagnostic and therapeutic value.12 A systematic
identification of the dynamic changes of proteins involved
in inflammation in the pleural cavity, however, has not
been well clarified. An improved understanding in the
pattern recognition of proteins in pleural fluids is poten-
tially able to classify CPE for clinical management. The aim
of this study was to investigate the proteomics profiling
data of infectious parapneumonic effusions obtained using
matrix-assisted laser desorption/ionization time-of-flight
mass spectrometry (MALDI-TOF MS), hopefully to obtain
some potential diagnostic value and even guide the timing
of surgical intervention.Materials and methods
Patients and supernatant specimens of pleural fluid
The study population consisted of patients aged <18 years
who had community-acquired pneumonia requiring hospi-
talization in Chang Gung Children’s Hospital (Taoyuan,
Taiwan) between January 2005 and January 2007. Patients
with PE were consecutively enrolled into our study and all
underwent real-time chest sonography and thoracentesis
irrespective of size of pleural effusion. This study was
approved by the Ethic Committee of Chang Gung Memory
Hospital. Informed written consent was obtained from the
parents of all study participants.
Pleural fluid was collected using a standard thor-
acocentesis technique after chest sonography prior to
intervention procedures. Pleural fluid was immediately
analyzed for pH, total cell counts, and differential cell
count, and for protein, glucose, and LDH concentrations.
Pleural fluid for pH analysis was collected anaerobically
with heparin and measured in a handheld analyzer (i-STATA
Portable Clinical Analyzer; i-STATA Corporation; East
Windsor, NJ, USA). A 4-mL sample of specimen was mixed
with 3.2% sodium citrate solution in a ratio of 9:1 pleural
fluid to citrate, which were immediately immersed in ice
separately and centrifuged at 1500g for 10 minutes. The
cell-free supernatant from each sample was stored
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analysis (Bruker Daltonics, Bremen, Germany).
Patients were classified into two groups, either with CPE
or non-CPE, based on the biochemical characteristics of the
fluid. Patients with CPE were diagnosed if the fluid met at
least two of the following criteria: a pleural fluid pH
of  7.2, a LDH level of  1000 U/L, and a glucose level of
40 mg/dL. Otherwise, patients with non-CPE were defined
as those whose pleural fluid met only one or none of the
above criteria. In clinical practice, antibiotic selection
covered the likeliest organisms and was adjusted after
culture results were obtained. Intervention procedures for
intercostal drainage including tube thoracostomy or video-
assisted thoracic surgery were considered if patients had
persistent fever >39C, dyspnea, and sepsis despite
appropriate antibiotic therapy. Streptococcus pneumoniae
infection was defined by a positive result in blood or pleural
fluid culture or the detection of antigens in the pleural fluid
by latex agglutination testing. Acute pneumococcal infec-
tion was also included for patients who had necrotic lung
parenchyma with a positive urine test for S. pneumoniae
(Binax, Portland, ME, USA).
Sample preparation using hydrophobic magnetic
beads
For protein/peptide purification, each sample was pre-
pared automatically using a robot for magnetic beads
assisted extraction (ClinProt; Bruker Daltonics). The robotic
workflows are virtually identical to the workflows per-
formed manually for preparing serum samples,13 apart from
the inherent differences due to the switch-over to auto-
mation (simultaneous spotting, marginally shorter time
frames, etc.). Three purification kits characterized by hy-
drophobic interaction chromatography (HIC) including C3,
C8, and C18, were tested to identify the best functionalized
magnetic beads (MB), which can obtain abundant protein
spectra. Briefly, 10 mL of pleural effusion were mixed well
with 5 mL of magnetic beads and 15 mL of MB-HIC binding
buffer. Magnetic beads bound by interacted proteins were
then separated using a magnetic bead separator and were
washed for 20 seconds three times in 100 mL of MB-HIC
washing solution. Bound peptides or proteins were eluted
with 10 mL eluting buffer containing 50% acetonitrile and
prepared for mass spectrum by MALDI-TOF MS.
Mass spectrometry
A ground steel plate (Bruker Daltonics) was used for
extracted sample spotting. One mL of each eluted sample
was diluted in 9 mL matrix solution containing a-cyano-4-
hydroxycinnamic acid (7 mg/mL) in 70% acetonitrile with
0.1% trifluoroacetic acid and then spotted 1 mL to each well
on the ground steel plate. Four analytical replicates were
prepared and spotted onto the MALDI target. All prepara-
tions were performed at room temperature.
Positive ion mass spectra were obtained on an Ultraflex
TOF/TOF mass spectrometer (Bruker Daltonics) with linear
mode after the sample was dried at room temperature. A
337-nm nitrogen laser irradiated and ionized the samples at
a shot rate of 25 Hz. Each spectrum had a summation of1500 laser shots with a mass range of 1000e25,000 Da,
which was controlled by FlexControl acquisition software
(Version 3.0; Bruker Daltonics). Mass calibration was ach-
ieved using a mixture of standard peptides and proteins
(angiotensin II, ACTH, insulin, and myoglobin) to maintain
mass accuracy at >500 ppm.
Data analysis
To analyze the mass spectra patterns of pleural fluids,
ClinProTools software (version 2.0.365, Bruker Daltonics)
was firstly employed for peak definition (signal/ noise > 3),
integration (end-point level), mass recalibration (0.2 %
maximal peak shift), area normalization (against total ion
count), and statistical analysis (Wilcoxon/KruskaleWallis
test). Each corresponding peak throughout the spectra
within each studied set was carefully inspected.
For rapid classification, the quick classifier (QC), support
vector machine, and genetic algorithm (GA) methods
embedded in the ClinProTools software (Bruker Daltonics)
were implemented for model generation. To reduce classi-
fier complexity, mass/charge (m/z) values with p < 0.05
(Wilcoxon/KruskaleWallis test) were selected for model
generation across all experiments. In GA classification, the
K-nearest neighbor text categorization method was used to
select classifiers and validate their recognition rates by the
leave-one-out method for cross validation. The perfor-
mance of the classification models was evaluated by
recognition capability (RC) and cross validation achieve-
ment (CVA). The RC is essential to internally evaluate the
fitness of the classification models, whereas CVA is crucial to
measure robustness of the resulting classification models.
In the initial model construction stage, the data from the
training set were used to establish models as well as perform
cross-validation procedures. For external validation, an in-
dependent data setwas employed to examine the robustness
of the established models. The selected model for classifi-
cation was then used for predicting the need of advanced
interventional procedure. The positive predictive value
(PPV) and negative predictive value (NPV) were used to
evaluate the performance and reliability of the models.
Statistical analysis
Statistical analysis was performed using SPSS version 10.0
for Windows (SPSS Inc., Chicago, IL, USA). A p value < 0.05
was considered to indicate statistical significance. Para-
metric data were compared using analysis of variance fol-
lowed by Bonferroni’s multiple comparison test. When the
data were not normally distributed, or were nonpara-
metric, the KruskaleWallis test was used as appropriate.
Categorical data were analyzed using contingency table
analysis and the Chi-square or Fisher’s exact test.
Results
Patient characteristics and work flow of the study
Fifty-seven children with pneumonia followed by PE were
consecutively enrolled into our study. The mean age was
486 C.-Y. Chiu et al.5.5  4.3 years. Patients received intervention procedures
within 24 hours after thoracentesis, and pleural fluid
met all three criteria of CPE (pH  7.2, LDH  1000 U/L,
and glucose  40 mg/dL) in 13 (23%) patients. There were
also 13 patients (23%) whose fever subsided within 24 hours
after thoracentesis and the fluid met none of the criteria of
CPE. These 26 well-characterized patients with or without
CPE (n Z 13 in each group) were used for the construction
of the classification models. The comparisons of pleural
variables and characteristics of 26 well-characterized pa-
tients with and without CPE for model generation are
shown in Table 1. An independent set contained another 31
PEs that did not meet all three criteria of CPE or non-CPE
was then used for external validation of the constructed
classification models. The prediction for the need of sur-
gical intervention was also evaluated by using selected
classification models. Fig. 1 illustrates the workflow of this
study.
Sample preparation and C8-functionalized MB
Fifty-seven mass spectra generated by MALDI-TOF MS after
fractionating samples with each functionalized MB were
used for analysis in subsequent studies. Three different
purification kits (MB-C3, MB-C8, and MB-C18) are commer-
cially available from Bruker Daltonics. After comparing the
protein profiles from the use of these three kits, C8-
functionalized MB (MB-C8) were identified to result in rich
peak contents of the spectra and the highest
reproducibility.
Clinical efficacy of the analytical strategy
The MS spectra of pleural fluids derived from 26 well-
characterized patients in the training set were analyzed,Table 1 Comparison of characteristics of patients and pleural
non-CPE
Characteristics Non-CP




Days of fever elapsed prior to thoracentesis 5.0  3
Pathogen
Streptococcus pneumoniae 9 (69)
Unknown 4 (31)
Hemogram
WBC,  109/L 12.4 
Hb, g/dL 10.3 
Platelet, 109/L 277.1 
CRP, mg/L 163.1 
Pleural effusion
pH 7.42 
Glucose, mg/dL 73.6 
LDH, IU/L 546.2 
Hospital stay, d 9.9  3
Data are presented as n (%) or mean  standard deviation.
CRP Z C-reactive protein; Hb Z hemoglobin; LDH Z lactate dehydrand classification models were constructed via several
statistical approaches including quick classifier, support
vector machine, and GA. A total of 123 peaks were identi-
fied from the MS spectra of pleural fluids. Among them, 23
peaks which were significant with p < 0.05 via Wilcoxon/
KruskaleWallis test were used as classifiers. A series of
models were constructed and representative ones including
their RC and CVA are listed in Table 2. Three m/z peaks
(2127, 2232, and 2427) were significantly downregulated
and were selected as classifiers (Fig. 2). Model 7, containing
the above-mentioned three significant peaks, has 73%
sensitivity and 100% specificity, and was able to classify CPE
with a PPV of 100% and an NPV of 73% (11/15). In the
classification analysis for requiring subsequent aggressive
intervention, compared to the PPV of 100% using
biochemical markers, this model still had a remarkable PPV
of 77% (13/17) despite its NPV of 50% (7/14).
Discussion
Pleural effusion, an accumulation of pleural fluid, contains
proteins originating from plasma filtrate and parenchymal
interstitial spaces of lungs especially when lung tissues are
damaged. In pleural exudates, most of the abundant pro-
teins were matched with the proteins in plasma, such as
albumin, microglobulin, haptoglobin, glycoprotein, apoli-
poprotein, and immunoglobin.11,14 Low abundance pro-
teins, cystatin C, transthyretin, b-2-microgloblin, and
transferrin, detected in pleural exudates associated with
pneumonia have also been reported in the literature to be
found in plasma.12,15 A C8 adsorbent is an ideal tool for
purification of both peptides and proteins. In addition, MB-
C8 have been reported to enrich a specific subset of plasma
proteins based on their absorption by this hydrophobic
functionality.16,17 In this study, the proteomic profiling ofvariables in complicated parapneumonic effusion (CPE) and
E (n Z 13) CPE (n Z 13) p
.4 4.4  4.1 0.225
7 (54) 0.695
6 (46)
.6 7.5  4.2 0.118
10 (77) 1.000
3 (23)
6.6 22.4  6.7 0.001
1.3 9.9  2.7 0.574
132 376.2  211 0.152
104 192.5  80 0.295
0.10 6.89  0.26 <0.001
18.1 11.6  16.9 <0.001
422.8 7,762  9,768 <0.001
.2 15.3  4.7 0.002
ogenase; WBC Z white blood cell.
Figure 1. Flowchart of the study.
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result in rich peak contents of the spectra and the highest
reproducibility, indicating that the proteins/peptides ob-
tained using C8 can not only represent the characteristics
of pleural exudates, but also accurately reflect various
pathological processes.
Several proteomic studies on pleural effusions by using a
combination of two-dimensional gel electrophoresis and MS
have been reported.11,18e20 The changes of protein in the
pleural effusions during the process of diseases, however,
could not be established precisely due to the subtleties of
the changes and high variability between individuals. By
contrast, protein profiling by MALDI-TOF MS after sample
fractionation with magnetic beads is a robust, precise, and
rapid technique for the investigation of protein pattern
changes and has been applied in various disease research
for biomarker discovery.16,21 Unlike the research published
so far, the dynamic changes of protein during the process of
pleural infection caused by pneumonia was well established
in this study by using MALDI-TOF MS combined with C8Table 2 Comparison of recognition capability (RC), cross-valida
independent set for the classification models
Model Algorithms No. peaks CVA (%)
1 QC 14 77.3
2 SVM 21 83.9
3 GA 3 74.0
4 GA 5 72.0
5 GA 10 74.8
6 GA 15 71.7
7 Optimized GAa 5 95.5
a Optimized GA, enforced selection of specific m/z values with inte
during GA model construction.
CPE Z complicated parapneumonic effusion; GA Z genetic algori
SVM Z support vector machine.magnetic beads. Furthermore, a well-recognized protein
pattern also provides an alternative approach for manage-
ment of PE.
In this study, the data of proteomic spectra generated
from PE were analyzed and pattern recognition models
were successfully generated by ClinProTools software
(Bruker Daltonics) for classification and prediction. The
existence of 23 differential proteomic peaks between CPE
and non-CPE indicates that broad pathological changes in
proteins are involved in the progression of pneumonia. In
addition, instead of a single protein type, a group of pro-
teins contributes to disease progression in pneumonia. A
pattern of three combined potential biomarkers effectively
distinguished CPE from non-CPE in this study. Three peaks
located at m/z 2127, 2232, and 2427 were, however, all
downregulated. Downregulated proteins that play major
roles in the activation of innate immune response to bac-
terial infection have also been reported in a comparative
proteomic study of plasma from children with pneumo-
coccal pneumonia.22 These findings indicate that proteinstion achievement (CVA), and positive predictive value of an
RC (%) PPV of independent










nsity >5% of total and p < 0.05 via Wilcoxon/KruskaleWallis test
thm; PPV Z positive predictive value; QC Z quick classifier;
Figure 2. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry spectra of 26 samples for model con-
struction. (A) The gel view showing the spectra of two classes of parapneumonic effusions (top, noncomplicated parapneumonic
effusion; bottom, complicated parapneumonic effusion). (B) A region of mass spectra from 2100 to 2500 is enlarged to illustrate the
three significant peaks (gray) that were enforced selected by genetic algorithm. Three significant downregulated m/z values (2127,
2232, and 2427) are highlighted. x axis, mass/charge in Daltons [m/z (Da)]; y axis, intensity [arbitrary units (arb.u.)].
488 C.-Y. Chiu et al.related to downregulation of immunity against bacterial
infections may play an important role in the pathogenesis
of pneumonia, and potentially become novel therapeutic
targets.
The model of pattern recognition established in this
study can classify CPE with 100% PPV and predict the need
of subsequent surgical intervention with 77% PPV. Despite
the high specificity of this model, there were still 4 of 15
non-CPE that could not be correctly classified. In clinical
practice, chest sonography can monitor the progression of
parapneumonic effusions by the demonstration of fibrin and
formation of fibrin septations.23 Furthermore, the process
of pleural infection is shown to be rapid and may progress
within one day.24 The high misclassification rate in this
study may therefore be due to the high variability of timing
for thoracentesis in the independent set. In addition, the
hesitation of parents for their children to receive invasive
intervention is believed to make the results of low PPV for
predicting the need of surgical intervention.
In conclusion, a combination of MB-based sample prep-
aration and MALDI-TOF MS analysis can effectively profile
pleural effusion proteome. In children with PE-associated
pneumonia, clinical proteomics analysis of PE can detect
changes in protein profiles reflecting disease states.
Despite the limitation of the small sample size in this study,
the application of MALDI-TOF MS in combination with adiagnostic model construction comprising three down-
regulated biomarkers provides an alternative approach for
predicting CPE and need for subsequent surgical interven-
tion. These findings indicate that pleural fluid proteins that
are downregulated during the progression of pneumonia
could potentially guide the management of infectious PE.Conflicts of interest
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